ICUI (STOCKS)
ICU Medical Inc
$129.320000
+3.640000 (+2.90%)
Prev close: $125.680000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Vivek Jain
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,194.80M
- Employees
- 15,000
- P/E (TTM)
- 4,274.83
- P/B (TTM)
- 1.46
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.91 | $1.73 | +0.1843 | +10.68% |
|
Sep 2025 (Q3)
|
$2.03 | $1.46 | +0.5680 | +38.85% |
|
Jun 2025 (Q2)
|
$2.10 | $1.53 | +0.5700 | +37.25% |
|
Mar 2025 (Q1)
|
$1.72 | $1.31 | +0.4144 | +31.74% |
Financial Statements
| Revenues | $2.23B |
| Benefits Costs and Expenses | $2.23B |
| Cost Of Revenue | $1.41B |
| Costs And Expenses | $2.23B |
| Gross Profit | $822.04M |
| Nonoperating Income/Loss | -$232.00K |
| Operating Expenses | $779.21M |
| Selling, General, and Administrative Expenses | $625.21M |
| Research and Development | $87.50M |
| Other Operating Expenses | $66.51M |
| Operating Income/Loss | $42.83M |
| Income/Loss Before Equity Method Investments | $4.36M |
| Income/Loss From Continuing Operations After Tax | $1.92M |
| Income/Loss From Continuing Operations Before Tax | $4.36M |
| Income/Loss From Equity Method Investments | -$1.19M |
| Income Tax Expense/Benefit | $2.44M |
| Income Tax Expense/Benefit, Current | $16.21M |
| Income Tax Expense/Benefit, Deferred | -$13.77M |
| Interest And Dividend Income, Operating | $10.31M |
| Interest Expense, Operating | $93.34M |
| Interest Income/Expense After Provision For Losses | -$83.03M |
| Interest Income/Expense Operating, Net | -$83.03M |
| Net Income/Loss | $732.00K |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $732.00K |
| Net Income/Loss Available To Common Stockholders, Basic | $732.00K |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | $0.03 |
| Diluted Earnings Per Share | $0.03 |
| Basic Average Shares | 24,640,000 |
| Diluted Average Shares | 24,904,000 |
| Assets | $4.05B |
| Current Assets | $1.19B |
| Inventory | $615.86M |
| Other Current Assets | $574.70M |
| Noncurrent Assets | $2.86B |
| Fixed Assets | $451.82M |
| Intangible Assets | $633.56M |
| Other Non-current Assets | $1.77B |
| Liabilities | $1.93B |
| Current Liabilities | $498.86M |
| Accounts Payable | $154.37M |
| Other Current Liabilities | $344.49M |
| Noncurrent Liabilities | $1.43B |
| Commitments and Contingencies | $0.00 |
| Equity | $2.12B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.12B |
| Liabilities And Equity | $4.05B |
| Net Cash Flow From Operating Activities | $179.85M |
| Net Cash Flow From Operating Activities, Continuing | $179.85M |
| Net Cash Flow From Investing Activities | $122.23M |
| Net Cash Flow From Investing Activities, Continuing | $122.23M |
| Net Cash Flow From Financing Activities | -$311.53M |
| Net Cash Flow From Financing Activities, Continuing | -$311.53M |
| Exchange Gains/Losses | $8.85M |
| Net Cash Flow | -$603.00K |
| Net Cash Flow, Continuing | -$9.45M |
| Comprehensive Income/Loss | $105.50M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $105.50M |
| Other Comprehensive Income/Loss | $104.77M |